HC Wainwright reiterated their buy rating on shares of OKYO Pharma (NASDAQ:OKYO – Free Report) in a report released on Thursday, Benzinga reports. They currently have a $7.00 price target on the…
Read More: https://zolmax.com/investing/okyo-pharma-nasdaqokyo-rating-reiterated-by-hc-wainwright/10716006.html
